
Keywords: نقشه 2; ALS; amyotrophic lateral sclerosis; NGF; nerve growth factor; NSC; neural stem cell; MAP 2; microtubule-associated protein 2; TrkA; tropomyosin receptor kinase; Amyotrophic lateral sclerosis; Cell therapy; SOD1 mice; Nerve growth factor;